Volume 13, Number 5—May 2007
Small Anellovirus Infections in Korean Children
|Group||Sex (M/F)||Age range (mean age)||No. tested||No. positive (%)||p value|
|Control||48/33||1 mo–15 y (47 mo)||81||28 (34.5)|
|Hepatitis||44/37||1 mo–15 y (58 mo)||81||29 (35.8)||1|
|HBV||8/12||1–15 y||20||10 (50)||0.30|
|HCV||11/0||3–10 y||11||5 (45.4)||0.71|
|Others||10/9||0–13 y||19||7 (36.8)||0.93|
|Unknown||15/16||0–13 y||31||7 (22.5)||0.3|
|ARD||22/18||0–5 y (18 mo)||40||27 (67.5)||0.001†|
|Vasculitis||22/8||1–10 y (46 mo)||30||10 (33.3)||0.91|
|KD||9/3||1–9 y||12||6 (50)||0.47|
|HSP||13/5||2–10 y||18||4 (22.2)||0.46|
|Total||136/96||1 mo–15 y||232||94 (40.5)|
*SAV, small anellovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; ARD, acute respiratory tract disease; KD, Kawasaki disease;
HSP, Henoch-Schonlein purpura.
†p<0.05, statistically significant.
Page created: June 23, 2010
Page updated: June 23, 2010
Page reviewed: June 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.